Cerda, Ivo H.
Therond, Alexandra
Moreau, Sacha
Studer, Kachina
Donjow, Aleksy R.
Crowther, Jason E.
Mazzolenis, Maria Emilia
Lang, Min
Tolba, Reda
Gilligan, Christopher
Ashina, Sait
Kaye, Alan D.
Yong, R. Jason
Schatman, Michael E.
Robinson, Christopher L.
Article History
Accepted: 13 December 2023
First Online: 4 January 2024
Compliance with Ethical Standards
:
: Author IHC receives consulting fees from Layer Health. AT, SM, and ARD are co-founders and equity holders of AugMend Health. ML is an Associate Partner at MEDA Angels and Vice President of Operations at AMXRAAS. RT receives consulting fees from Abbott and Medtronic. AS provided consulting and teaching services for Allergan/Abbvie, Eli Lilly and Company, Impel NeuroPharma, Linpharma, Lundbeck, Satsuma, Percept, Pfizer, Teva, and Theranica. MES serves as a research consultant to Modoscript and was a member of an Advisory Committee for Syneos Health. CLR is an equity owner and advisor for AugMend Health.
: This article does not contain any studies with human or animal subjects performed by any of the authors.